Dyne Therapeutics, citing trial data, said it will ask the FDA to approve DYNE-251, its therapy for DMD amenable to exon 51 skipping.

This spicy list got us thinking: how can you get the most out of the most popular sex positions of 2025? So we talked to ...

The global mRNA quality monitoring market size was valued at USD 1.28 billion in 2024 and is predicted to hit around USD 2.5 ...

Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

As the year comes to a close, people may be evaluating whether they reached their personal goals, but Pornhub is looking back ...

A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

To develop the new rapid polymerase chain reaction (PCR) test for HCV, the scientists used the DASH® (Diagnostic Analyzer for ...

A nucleoside-modified mRNA (modRNA) influenza vaccine showed greater protection against influenza-like illness compared to a ...

Knowing what is possible can bring light in the darkest of places. It can help protect us from becoming inactive and resigned ...

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...